Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer

por Peng Su, Ziqi Peng, Boyang Xu, Bowen Yang, Feng Jin
Publicado 2021

Palmatine sensitizes chemoresistant triple negative breast cancer cells via efflux inhibition of multidrug resistant protein 1.

por Selase Ativui, Cynthia A. Danquah, Newman Osafo, Williams Adu, Michael Ofori
Publicado 2021

Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study

por Abdulwahab Abuderman, Ola Harb, Loay Gertallah
Publicado 2020

Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells

por Zuo R, Zhang J, Song X, Hu S, Gao X, Wang J, Ji H, Ji C, Peng L, Si H, Li G, Fang K, Zhang J, Jiang S, Guo D
Publicado 2021

The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer—A Meta-Analysis

por Zilin Zhang, Kai Ma, Jing Li, Yeneng Guan, Chaobo Yang, Aqin Yan, Hongda Zhu
Publicado 2021

Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases

por Seung-Uon Shin, Hyun-Mi Cho, Rathin Das, Hava Gil-Henn, Sundaram Ramakrishnan, Ahmed Al Bayati, Stephen F. Carroll, Yu Zhang, Ankita P. Sankar, Christian Elledge, Augustin Pimentel, Marzenna Blonska, Joseph D. Rosenblatt
Publicado 2021

Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls

por Sara Bravaccini, Roberta Maltoni
Publicado 2021

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy

por Bingqing Xia, Bingqing Xia, He Wang, Zhe Wang, Zhaoxia Qian, Qin Xiao, Yin Liu, Zhimin Shao, Shuling Zhou, Weimin Chai, Chao You, Yajia Gu
Publicado 2021

Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer

por Ka‐Chun Mok, Ho Tsoi, Ellen PS Man, Man‐Hong Leung, Ka Man Chau, Lai‐San Wong, Wing‐Lok Chan, Sum‐Yin Chan, Mai‐Yee Luk, Jessie Y.W. Chan, Jackie K.M. Leung, Yolanda H.Y. Chan, Sellma Batalha, Virginia Lau, David C.W. Siu, Terence K.W. Lee, Chun Gong, Ui‐Soon Khoo
Publicado 2021

Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer

por Li X, Zou Q, Zhang J, Zhang P, Zhou X, Yalamarty SSK, Liang X, Liu Y, Zheng Q, Gao J
Publicado 2020

Terminal Cyclohexane-Type Meroterpenoids from the Fruiting Bodies of Ganoderma cochlear

por Fu-Ying Qin, Te Xu, Yan-Peng Li, Hao-Xing Zhang, Dan Cai, Li-Zhong Liu, Yong-Xian Cheng, Yong-Xian Cheng
Publicado 2021

An Update on the Molecular Pathology of Metaplastic Breast Cancer

por McCart Reed AE, Kalaw EM, Lakhani SR
Publicado 2021

Current advances in biomarkers for targeted therapy in triple-negative breast cancer

por Fleisher B, Clarke C, Ait-Oudhia S
Publicado 2016

Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer

por Mirjana Prvanović, Milica Nedeljković, Nasta Tanić, Tijana Tomić, Tanja Terzić, Zorka Milovanović, Zlatko Maksimović, Nikola Tanić
Publicado 2021

miR-29b-3p promotes progression of MDA-mB-231 triple-negative breast cancer cells through downregulating TRAF3

por Zhang,Bao, Shetti,Dattatrya, Fan,Conghui, Wei,Kun
Publicado 2019

Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification

por Yubao Zhang, Xiaoran Ma, Huayao Li, Jing Zhuang, Fubin Feng, Lijuan Liu, Cun Liu, Changgang Sun, Changgang Sun
Publicado 2021

Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers

por Al-saraireh YM, Alshammari FOFO, Youssef AM, Al-Tarawneh F, Al-Sarayreh S, Almuhaisen GH, Satari AO, Al-Shuneigat J, Alrawashdeh HM
Publicado 2021

Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype

por Marina K. Ibragimova, Matvey M. Tsyganov, Nikolai V. Litviakov
Publicado 2021

Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach

por Hana Kim, Hyo Jung Kim, Hongsik Kim, Hye Ryeon Kim, Hyunji Jo, Joohyun Hong, Ryul Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Se Kyung Lee, Haeyoung Kim, Soo-Yong Shin, Yeon Hee Park
Publicado 2021

Antiangiogenic therapy for breast cancer with triple negative phenotype

por Inna P. Ganshina, Kristina A. Ivanova, Olga O. Gordeeva, Aleksandr V. Arkhipov, Liudmila G. Zhukova
Publicado 2021